• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1型神经纤维瘤病相关神经纤维瘤的临床特征及外科治疗]

[Clinical features and surgical treatments of neurofibromas associated with neurofibromatosis type 1].

作者信息

Liu Hanjie, Yu Lebao, Wang Bo, Liu Pi'nan, Liu Song, Li Dezhi

机构信息

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, P. R. China.

出版信息

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Oct 15;38(10):1186-1192. doi: 10.7507/1002-1892.202407007.

DOI:10.7507/1002-1892.202407007
PMID:39433491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522527/
Abstract

OBJECTIVE

To explore the clinical features, surgical treatment, and effectiveness of neurofibromas associated with neurofibromatosis type 1 (NF1).

METHODS

A clinical data of 41 patients with NF1 admitted between December 2018 and April 2024 was retrospectively analyzed. There were 15 males and 26 females, with an average age of 27.5 years (range, 5-61 years). Only one type of neurofibroma existed in 3 patients and the rest of the patients had more than two types of neurofibromas. Fourteen patients had total resection of multiple cutaneous neurofibromas (CNF). Eighteen patients of diffuse neurofibromas underwent total, near-total, or subtotal resection. Among the 13 patients of localized nodular neurofibromas, 9 of benign tumors underwent total sub-capsular resection and 4 of malignant peripheral nerve sheath tumor (MPNST) underwent maginal resection, and only 1 underwent postoperative radiotherapy and chemotherapy. Among the 15 patients of plexiform neurofibromas (PNF), 5 patients underwent both superficial and deep PNF resection, 2 underwent the superficial PNF resection, and 8 underwent the large nodular lesions in the deep PNF resection. There were 8 MPNST, of which 7 cases underwent total sub-capsular resection and large tumor capsule resection under neurophysiological monitoring, and 1 case with the tumor located on the top of the head underwent wide resection and skin grafting. One patient underwent proton knife therapy after surgery, 2 patients did not receive radiotherapy, and the remaining patients received conventional radiotherapy.

RESULTS

All patients were followed up after surgery, and the follow-up time was 3-66 months, with an average of 25.0 months. Patients with CNF recovered satisfactorily after surgery, and there was no recurrence during follow-up. Patients with diffuse neurofibromas relieved preoperative symptoms after surgery. Three patients with diffuse neurofibromas located in the head and face recurred during follow-up. The patients with benign localized nodular neurofibromas recovered well after surgery, and only 1 patient had transient regional neuralgia after surgery. Among the patients with MPNST, 2 patients died of recurrence and lung metastasis, while the remaining 2 patients had no recurrence and metastasis during follow-up. All preoperative symptoms disappeared in patients with benign PNF, and no tumor recurrence was observed during follow-up. Two patients with PNF located in the brachial plexus had difficulty in shoulder abduction after surgery, 1 patient with PNF located in vagus developed hoarseness after surgery. Among the 8 patients with MPNST in PNF, 1 died of lung metastases and 1 died of systemic failure. The remaining 6 patients were in stable condition during follow-up, and no tumor recurrence or metastasis was observed.

CONCLUSION

According to the clinical features of neurofibromas in patients with NF1, choosing appropriate surgical approaches can obtain good effectiveness. Because of the difficulty of completely resection, diffuse neurofibromas, especially those located in the head and face, are prone to recurrence after surgery. MPNST has the worst prognosis, high incidence of recurrence/metastasis, and short survival period. Total resection combined with radiotherapy can decrease local recurrence.

摘要

目的

探讨1型神经纤维瘤病(NF1)相关神经纤维瘤的临床特征、手术治疗方法及疗效。

方法

回顾性分析2018年12月至2024年4月收治的41例NF1患者的临床资料。其中男性15例,女性26例,平均年龄27.5岁(5 - 61岁)。3例患者仅有一种类型的神经纤维瘤,其余患者有两种以上类型的神经纤维瘤。14例患者接受了多发性皮肤神经纤维瘤(CNF)全切术。18例弥漫性神经纤维瘤患者接受了全切、次全切或部分切除术。13例局限性结节性神经纤维瘤患者中,9例良性肿瘤行包膜下全切术,4例恶性外周神经鞘瘤(MPNST)行边缘切除术,仅1例术后接受放疗和化疗。15例丛状神经纤维瘤(PNF)患者中,5例患者接受了深浅部PNF切除术,2例接受了浅部PNF切除术,8例接受了深部PNF的大结节性病变切除术。有8例MPNST,其中7例在神经电生理监测下行包膜下全切和大肿瘤包膜切除术,1例肿瘤位于头顶的患者行广泛切除术及植皮术。1例患者术后接受质子刀治疗,2例患者未接受放疗,其余患者接受常规放疗。

结果

所有患者术后均进行随访,随访时间3 - 66个月,平均25.0个月。CNF患者术后恢复满意,随访期间无复发。弥漫性神经纤维瘤患者术后术前症状缓解。3例位于头面部的弥漫性神经纤维瘤患者在随访期间复发。良性局限性结节性神经纤维瘤患者术后恢复良好,仅1例术后出现短暂性局部神经痛。MPNST患者中,2例死于复发和肺转移,其余2例随访期间无复发和转移。良性PNF患者术前症状均消失,随访期间未观察到肿瘤复发。2例位于臂丛神经的PNF患者术后出现肩外展困难,1例位于迷走神经的PNF患者术后出现声音嘶哑。8例PNF合并MPNST患者中,1例死于肺转移,1例死于全身衰竭。其余6例患者随访期间病情稳定,未观察到肿瘤复发或转移。

结论

根据NF1患者神经纤维瘤的临床特征,选择合适的手术方式可获得较好疗效。由于弥漫性神经纤维瘤完全切除困难,尤其是位于头面部者,术后易复发。MPNST预后最差,复发/转移率高,生存期短。全切联合放疗可降低局部复发率。

相似文献

1
[Clinical features and surgical treatments of neurofibromas associated with neurofibromatosis type 1].[1型神经纤维瘤病相关神经纤维瘤的临床特征及外科治疗]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Oct 15;38(10):1186-1192. doi: 10.7507/1002-1892.202407007.
2
Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.NF I患者中丛状和弥漫性神经纤维瘤与恶性外周神经鞘膜瘤的关联:一项全身MRI评估
Skeletal Radiol. 2024 Apr;53(4):769-777. doi: 10.1007/s00256-023-04497-z. Epub 2023 Oct 31.
3
The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.妊娠对 1 型神经纤维瘤病中神经纤维瘤生长动力学的影响。
PLoS One. 2020 Apr 28;15(4):e0232031. doi: 10.1371/journal.pone.0232031. eCollection 2020.
4
Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.颅内神经恶性外周神经鞘瘤:病例系列回顾
Auris Nasus Larynx. 2010 Oct;37(5):539-45. doi: 10.1016/j.anl.2010.02.009.
5
[Analysis of clinical features, treatment methods, and prognostic influence factors in patients with malignant peripheral nerve sheath tumor].[恶性周围神经鞘膜瘤患者的临床特征、治疗方法及预后影响因素分析]
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Oct 15;38(10):1193-1201. doi: 10.7507/1002-1892.202406040.
6
Sporadic superficial diffuse neurofibromas with repeated local recurrence over many years and a tendency toward malignant change: a report of 3 cases.多年来多次局部复发且有恶性转化倾向的散发性浅表弥漫性神经纤维瘤:3 例报告。
Am J Surg Pathol. 2013 Jul;37(7):987-94. doi: 10.1097/PAS.0b013e31827c96f4.
7
ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.1型神经纤维瘤病相关周围神经鞘瘤中的ERBB2和ERBB3生长因子受体、神经调节蛋白-1、CD44和Ki-67增殖指数
Anticancer Res. 2022 May;42(5):2327-2340. doi: 10.21873/anticanres.15712.
8
Plexiform neurofibroma with and without associated malignant peripheral nerve sheath tumor: a clinicopathologic and immunohistochemical analysis of 54 cases.伴有和不伴有相关恶性外周神经鞘瘤的丛状神经纤维瘤:54例临床病理及免疫组化分析
Mod Pathol. 1998 Jul;11(7):612-7.
9
Association between benign and malignant peripheral nerve sheath tumors in NF1.1型神经纤维瘤病中良性与恶性周围神经鞘膜瘤的关联
Neurology. 2005 Jul 26;65(2):205-11. doi: 10.1212/01.wnl.0000168830.79997.13.
10
Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.1型神经纤维瘤病患者腮腺内面神经多发丛状神经纤维瘤
Int J Pediatr Otorhinolaryngol. 2008 May;72(5):553-7. doi: 10.1016/j.ijporl.2008.01.022. Epub 2008 Mar 7.

本文引用的文献

1
Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods.无创治疗皮肤神经纤维瘤(cNFs):四种方法随机前瞻性直接比较的结果。
J Am Acad Dermatol. 2024 Apr;90(4):767-774. doi: 10.1016/j.jaad.2023.11.058. Epub 2023 Dec 10.
2
Management of neurofibromatosis type 1-associated plexiform neurofibromas.1 型神经纤维瘤病相关丛状神经纤维瘤的治疗管理。
Neuro Oncol. 2022 Nov 2;24(11):1827-1844. doi: 10.1093/neuonc/noac146.
3
Morbidity and Function Loss After Resection of Malignant Peripheral Nerve Sheath Tumors.恶性外周神经鞘瘤切除术后的发病率和功能丧失。
Neurosurgery. 2022 Mar 1;90(3):354-364. doi: 10.1093/neuros/nyab342. Epub 2021 Sep 15.
4
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.修订的 1 型神经纤维瘤病和莱格氏综合征的诊断标准:国际共识建议。
Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19.
5
Diagnostic Pathology of Tumors of Peripheral Nerve.周围神经肿瘤的诊断病理学。
Neurosurgery. 2021 Feb 16;88(3):443-456. doi: 10.1093/neuros/nyab021.
6
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.30 岁以下非横纹肌肉瘤软组织肉瘤患者的基于风险的治疗策略(ARST0332):儿童肿瘤学组前瞻性研究。
Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2. Epub 2019 Nov 27.
7
Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience.神经纤维瘤病 1 中的周围神经肿瘤:我们经验中的管理概述及手术治疗适应证。
Neurol India. 2019 Jan-Feb;67(Supplement):S38-S44. doi: 10.4103/0028-3886.250697.
8
Cutaneous neurofibromas: Current clinical and pathologic issues.皮肤神经纤维瘤:当前的临床和病理问题。
Neurology. 2018 Jul 10;91(2 Suppl 1):S5-S13. doi: 10.1212/WNL.0000000000005792.
9
Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma.对于腹膜后肉瘤,采用术前(有或无术中)放疗联合根治性手术切除的积极策略可改善局部控制。
J Surg Oncol. 2017 May;115(6):746-751. doi: 10.1002/jso.24557. Epub 2017 Jan 27.
10
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.司美替尼在1型神经纤维瘤病相关丛状神经纤维瘤中的活性
N Engl J Med. 2016 Dec 29;375(26):2550-2560. doi: 10.1056/NEJMoa1605943.